| Literature DB >> 10178678 |
Abstract
Over the last decade, the costs of blood procurement have increased as a result of regulatory pressure and scientific progress in understanding transfusion-transmitted disease. At the same time, hospitals are under tremendous pressure to reduce costs. Hospital blood banks are evaluating different strategies, including in-house or "out-sourced" blood collection, as a means of reducing collections. These decisions, however, should be made on assessments of the total cost of a safe and reliable blood supply: recruitment, collection, donor management, testing, manufacturing/processing, quality control, inventory management, quality assurance, regulatory, overhead and availability. If all of these costs are considered, it is unlikely that cost reduction can be achieved through hospital collections.Entities:
Mesh:
Year: 1997 PMID: 10178678 DOI: 10.1016/s0955-3886(97)00052-0
Source DB: PubMed Journal: Transfus Sci ISSN: 0955-3886